RTC

Riverview Trust Company Portfolio holdings

AUM $82.8M
1-Year Est. Return 15.31%
This Quarter Est. Return
1 Year Est. Return
+15.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$80.3M
AUM Growth
-$21M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
603
New
Increased
Reduced
Closed

Top Sells

1 +$4.05M
2 +$2.77M
3 +$2.43M
4
AMZN icon
Amazon
AMZN
+$1.58M
5
META icon
Meta Platforms (Facebook)
META
+$1.52M

Sector Composition

1 Technology 11.05%
2 Financials 6.61%
3 Industrials 4.32%
4 Healthcare 3.36%
5 Consumer Staples 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
201
Western Union
WU
$2.95B
$8.63K 0.01%
1,025
-1,237
AEP icon
202
American Electric Power
AEP
$64.1B
$7.47K 0.01%
72
-648
STZ icon
203
Constellation Brands
STZ
$27.2B
$7.32K 0.01%
45
FUL icon
204
H.B. Fuller
FUL
$3.28B
$7.1K 0.01%
118
ARKK icon
205
ARK Innovation ETF
ARKK
$7.35B
$7.03K 0.01%
100
TAK icon
206
Takeda Pharmaceutical
TAK
$51.1B
$6.68K 0.01%
+432
DD icon
207
DuPont de Nemours
DD
$18B
$5.08K 0.01%
177
-6,384
ALGN icon
208
Align Technology
ALGN
$12.3B
$4.54K 0.01%
24
ANGI icon
209
Angi Inc
ANGI
$539M
$4.03K 0.01%
+264
TROW icon
210
T. Rowe Price
TROW
$23.2B
$3.47K ﹤0.01%
36
-36
VMEO
211
DELISTED
Vimeo
VMEO
$3.31K ﹤0.01%
819
REGN icon
212
Regeneron Pharmaceuticals
REGN
$77B
$3.15K ﹤0.01%
6
-80
NVO icon
213
Novo Nordisk
NVO
$277B
$2.9K ﹤0.01%
42
-42
NML
214
Neuberger Energy Infrastructure and Income Fund Inc
NML
$490M
$2.7K ﹤0.01%
300
DOW icon
215
Dow Inc
DOW
$19.6B
$1.96K ﹤0.01%
74
-2,010
VTRS icon
216
Viatris
VTRS
$14.8B
$1.74K ﹤0.01%
195
-995
DDD icon
217
3D Systems Corp
DDD
$403M
$1.54K ﹤0.01%
1,000
EMBC icon
218
Embecta
EMBC
$734M
$1.38K ﹤0.01%
142
-850
WAB icon
219
Wabtec
WAB
$39.3B
$1.26K ﹤0.01%
+6
ADNT icon
220
Adient
ADNT
$1.74B
$778 ﹤0.01%
40
-1,293
OGN icon
221
Organon & Co
OGN
$2.28B
$716 ﹤0.01%
74
-1,902
VFC icon
222
VF Corp
VFC
$7.35B
$588 ﹤0.01%
50
KTB icon
223
Kontoor Brands
KTB
$3.3B
$462 ﹤0.01%
7
STEX
224
Streamex Corp
STEX
$144M
$428 ﹤0.01%
60
NVS icon
225
Novartis
NVS
$277B
-2,296